Delivery Order SPE2DB24D2013-SPE2DB24FCGRH

Award Date 4/11/24

Potential Completion Date 4/12/24

Potential Value $26K

Federal Agency

Defense Logistics Agency

Awardee

Amerisourcebergen Drug Corp KABZK8W6PQT3

Ultimate Awardee

Cencora, Inc. NWEGNLYTBDW4

NAICS Category

424210 - Drugs and Druggists' Sundries Merchant Wholesalers

PSC Category

6505 - Drugs And Biologicals

Federal Contract Vehicle

Not listed

Set-Aside Type

No Set-Aside Used

Extent Competed

Full and Open Competition

Major Defense Program

Not listed

Pricing Type

Firm Fixed Price

Place of Performance

Conshohocken, PA 19428, USA

Solicitation Procedures

Negotiated Proposal / Quote

Number Of Offers Received

Not listed

Legislative Mandate

Not listed

National Interest Action

Not listed

Research Type

Not listed

Primary Consortia Member

Not listed

This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical distribution company. The $25,702.01 firm fixed price contract is for the supply of Repatha, a 140 mg/mL injectable medication, to support the Department of Defense's medical treatment programs and facilities.

AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA facilities. The current delivery order was issued under this IDC. No set-aside designation was used for this award.

Generated 7/11/24, 10:18 AM